| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol binding | 2.64e-05 | 16 | 74 | 3 | GO:0019992 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.70e-05 | 118 | 74 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GAS2L1 TRIM2 KIF3B EML5 MYO5B FMN1 SPTAN1 APC MYH15 SORBS1 KIF5A HTT MPRIP | 1.81e-04 | 1099 | 74 | 13 | GO:0008092 |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 3.74e-04 | 8 | 74 | 2 | GO:0098882 | |
| GeneOntologyBiologicalProcess | synaptic signaling | MYO5B PTPRS ELFN1 ERC1 ERC2 UNC13C SORBS1 KIF5A RAPGEF2 SLC24A1 SLC7A11 HTT RIC3 GABRA2 GABRA4 | 2.27e-06 | 976 | 76 | 15 | GO:0099536 |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 1.34e-05 | 2 | 76 | 2 | GO:0044336 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | MYO5B PTPRS ERC1 ERC2 UNC13C KIF5A RAPGEF2 SLC24A1 SLC7A11 HTT RIC3 GABRA2 GABRA4 | 3.23e-05 | 931 | 76 | 13 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | MYO5B PTPRS ERC1 ERC2 UNC13C KIF5A RAPGEF2 SLC24A1 SLC7A11 HTT RIC3 GABRA2 GABRA4 | 3.23e-05 | 931 | 76 | 13 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | MYO5B PTPRS ERC1 ERC2 UNC13C KIF5A RAPGEF2 SLC24A1 SLC7A11 HTT RIC3 GABRA2 GABRA4 | 3.53e-05 | 939 | 76 | 13 | GO:0099537 |
| GeneOntologyBiologicalProcess | cell junction organization | MYO5B PTPRS ELFN1 ERC1 FMN1 CLDN16 APC ERC2 SORBS1 RAPGEF2 SLC7A11 GABRA2 GABRA4 | 5.15e-05 | 974 | 76 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of glutamate metabolic process | 8.00e-05 | 4 | 76 | 2 | GO:2000211 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 9.15e-05 | 123 | 76 | 5 | GO:0120034 | |
| GeneOntologyBiologicalProcess | vesicle cytoskeletal trafficking | 1.09e-04 | 67 | 76 | 4 | GO:0099518 | |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 1.99e-04 | 6 | 76 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 2.01e-04 | 31 | 76 | 3 | GO:0016082 | |
| GeneOntologyBiologicalProcess | synapse organization | MYO5B PTPRS ELFN1 ERC1 ERC2 SORBS1 RAPGEF2 SLC7A11 GABRA2 GABRA4 | 2.02e-04 | 685 | 76 | 10 | GO:0050808 |
| GeneOntologyBiologicalProcess | amino acid metabolic process | 2.22e-04 | 332 | 76 | 7 | GO:0006520 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 2.39e-04 | 569 | 76 | 9 | GO:0034329 | |
| GeneOntologyBiologicalProcess | regulation of calcium-dependent activation of synaptic vesicle fusion | 2.78e-04 | 7 | 76 | 2 | GO:0150037 | |
| GeneOntologyBiologicalProcess | anterograde dendritic transport of neurotransmitter receptor complex | 2.78e-04 | 7 | 76 | 2 | GO:0098971 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | 3.28e-04 | 251 | 76 | 6 | GO:1901605 | |
| GeneOntologyBiologicalProcess | regulation of glutamine family amino acid metabolic process | 3.70e-04 | 8 | 76 | 2 | GO:0000820 | |
| GeneOntologyCellularComponent | cytoplasmic region | 7.05e-07 | 360 | 76 | 10 | GO:0099568 | |
| GeneOntologyCellularComponent | cell cortex region | 2.15e-05 | 45 | 76 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | somatodendritic compartment | KIF3B MYO5B PTPRS ELFN1 APC KCNN3 ERC2 KIF5A RAPGEF2 SLC24A1 TRIM3 HTT RIC3 GABRA2 GABRA4 | 3.02e-05 | 1228 | 76 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | cell cortex | 6.01e-05 | 371 | 76 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | postsynapse | KIF3B MYO5B PTPRS ELFN1 ERC1 SPTAN1 APC KIF5A RAPGEF2 TRIM3 HTT GABRA2 GABRA4 | 7.05e-05 | 1018 | 76 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 7.76e-05 | 23 | 76 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | neuronal cell body | MYO5B PTPRS APC KCNN3 ERC2 KIF5A RAPGEF2 SLC24A1 HTT RIC3 GABRA2 | 2.07e-04 | 835 | 76 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | actin cytoskeleton | 2.37e-04 | 576 | 76 | 9 | GO:0015629 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 3.60e-04 | 8 | 76 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | cell body | MYO5B PTPRS APC KCNN3 ERC2 KIF5A RAPGEF2 SLC24A1 HTT RIC3 GABRA2 | 5.12e-04 | 929 | 76 | 11 | GO:0044297 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 6.27e-04 | 107 | 76 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 6.27e-04 | 107 | 76 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | microtubule | 6.98e-04 | 533 | 76 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 7.28e-04 | 817 | 76 | 10 | GO:0098978 | |
| GeneOntologyCellularComponent | actomyosin | 8.77e-04 | 117 | 76 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 9.05e-04 | 118 | 76 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.04e-03 | 317 | 76 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 1.15e-03 | 14 | 76 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.24e-03 | 583 | 76 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | axon | 1.40e-03 | 891 | 76 | 10 | GO:0030424 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.75e-03 | 141 | 76 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | cytosolic region | 2.12e-03 | 70 | 76 | 3 | GO:0099522 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 2.14e-03 | 19 | 76 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 2.62e-03 | 21 | 76 | 2 | GO:1902710 | |
| GeneOntologyCellularComponent | apical junction complex | 2.64e-03 | 158 | 76 | 4 | GO:0043296 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 3.02e-03 | 164 | 76 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.38e-03 | 277 | 76 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | supramolecular fiber | GAS2L1 CDK2AP2 KIF3B EML5 FMN1 SEPTIN9 SPTAN1 APC MYH15 KIF5A DNAH9 | 3.45e-03 | 1179 | 76 | 11 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | GAS2L1 CDK2AP2 KIF3B EML5 FMN1 SEPTIN9 SPTAN1 APC MYH15 KIF5A DNAH9 | 3.63e-03 | 1187 | 76 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | dendrite | 3.85e-03 | 858 | 76 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 3.91e-03 | 860 | 76 | 9 | GO:0097447 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 4.13e-03 | 179 | 76 | 4 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 4.13e-03 | 179 | 76 | 4 | GO:0030672 | |
| GeneOntologyCellularComponent | synaptic vesicle | 4.74e-03 | 300 | 76 | 5 | GO:0008021 | |
| GeneOntologyCellularComponent | distal axon | 5.03e-03 | 435 | 76 | 6 | GO:0150034 | |
| GeneOntologyCellularComponent | cilium | 5.18e-03 | 898 | 76 | 9 | GO:0005929 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 5.22e-03 | 899 | 76 | 9 | GO:0099513 | |
| GeneOntologyCellularComponent | secretory vesicle | ACTL7A PTPRB PTPRS ERC1 ADGRE3 SPTAN1 PSMB7 APC UNC13C PGM2 GABRA2 | 5.22e-03 | 1246 | 76 | 11 | GO:0099503 |
| GeneOntologyCellularComponent | exocytic vesicle | 6.21e-03 | 320 | 76 | 5 | GO:0070382 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 6.21e-03 | 201 | 76 | 4 | GO:0099634 | |
| Domain | ELKS/CAST | 1.63e-05 | 2 | 76 | 2 | IPR019323 | |
| Domain | Cast | 1.63e-05 | 2 | 76 | 2 | PF10174 | |
| Domain | NHL | 1.80e-05 | 13 | 76 | 3 | PS51125 | |
| Domain | GABAAa_rcpt | 2.43e-04 | 6 | 76 | 2 | IPR001390 | |
| Domain | - | 5.33e-04 | 39 | 76 | 3 | 2.120.10.30 | |
| Domain | NHL_repeat_subgr | 5.77e-04 | 9 | 76 | 2 | IPR013017 | |
| Domain | IG_FLMN | 7.20e-04 | 10 | 76 | 2 | SM00557 | |
| Domain | NHL | 7.20e-04 | 10 | 76 | 2 | PF01436 | |
| Domain | NHL_repeat | 7.20e-04 | 10 | 76 | 2 | IPR001258 | |
| Domain | 6-blade_b-propeller_TolB-like | 8.67e-04 | 46 | 76 | 3 | IPR011042 | |
| Domain | Filamin | 8.78e-04 | 11 | 76 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 8.78e-04 | 11 | 76 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 8.78e-04 | 11 | 76 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 8.78e-04 | 11 | 76 | 2 | IPR017868 | |
| Domain | Bbox_C | 1.66e-03 | 15 | 76 | 2 | IPR003649 | |
| Domain | BBC | 1.66e-03 | 15 | 76 | 2 | SM00502 | |
| Domain | Apc4_WD40_dom | 2.96e-03 | 20 | 76 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 2.96e-03 | 20 | 76 | 2 | PF12894 | |
| Domain | Quino_amine_DH_bsu | 3.58e-03 | 22 | 76 | 2 | IPR011044 | |
| Domain | GABAA/Glycine_rcpt | 3.91e-03 | 23 | 76 | 2 | IPR006028 | |
| Pubmed | NCOR1 RANBP2 KIF3B PTPRS ERC1 SPTAN1 APC ERC2 SORBS1 KIF5A RAPGEF2 SLC4A4 HSPA9 TRIM3 MPRIP | 2.28e-09 | 963 | 76 | 15 | 28671696 | |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 3.49e-07 | 7 | 76 | 3 | 36398873 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 9.72e-07 | 475 | 76 | 9 | 31040226 | |
| Pubmed | 1.07e-06 | 152 | 76 | 6 | 34299191 | ||
| Pubmed | 1.25e-06 | 360 | 76 | 8 | 33111431 | ||
| Pubmed | Genetic mapping of three GABAA receptor-subunit genes in the mouse. | 2.17e-06 | 12 | 76 | 3 | 8390964 | |
| Pubmed | GAS2L1 MYO5B PTPRS ERC1 SEPTIN9 SPTAN1 APC ERC2 SORBS1 RAPGEF2 SLC4A4 HSPA9 TRIM3 MPRIP | 2.36e-06 | 1431 | 76 | 14 | 37142655 | |
| Pubmed | 2.82e-06 | 13 | 76 | 3 | 36179691 | ||
| Pubmed | NCOR1 RANBP2 TCF7 MYO5B ERAP2 SEPTIN9 SPTAN1 GART UGDH APC MED12 HSPA9 MPRIP | 2.85e-06 | 1247 | 76 | 13 | 27684187 | |
| Pubmed | 3.76e-06 | 418 | 76 | 8 | 34709266 | ||
| Pubmed | USP34 ERC1 SPTAN1 ARID5B APC ERC2 SORBS1 KIF5A RAPGEF2 MTMR10 HSPA9 STAT6 MPRIP | 3.95e-06 | 1285 | 76 | 13 | 35914814 | |
| Pubmed | Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. | 4.48e-06 | 15 | 76 | 3 | 11092755 | |
| Pubmed | Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. | 4.71e-06 | 2 | 76 | 2 | 10489374 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27253063 | ||
| Pubmed | The Bruchpilot cytomatrix determines the size of the readily releasable pool of synaptic vesicles. | 4.71e-06 | 2 | 76 | 2 | 23960145 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28654863 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12226748 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31996256 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 29343442 | ||
| Pubmed | Two types of liver-specific F antigen are encoded by a locus located on chromosome 5 in mice. | 4.71e-06 | 2 | 76 | 2 | 3666846 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20519134 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19207358 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 14723704 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 37978273 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19458037 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.53e-06 | 588 | 76 | 9 | 38580884 | |
| Pubmed | EHBP1 RANBP2 ELFN1 ERC1 SEPTIN9 SPTAN1 TENM1 APC SORBS1 SLC4A4 HSPA9 GABRA2 | 6.46e-06 | 1139 | 76 | 12 | 36417873 | |
| Pubmed | 9.35e-06 | 128 | 76 | 5 | 30995482 | ||
| Pubmed | 1.13e-05 | 486 | 76 | 8 | 20936779 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 33914705 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 18482426 | ||
| Pubmed | Cytomatrix proteins CAST and ELKS regulate retinal photoreceptor development and maintenance. | 1.41e-05 | 3 | 76 | 2 | 30190286 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 25209271 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 34385712 | ||
| Pubmed | Modulation of GABAA receptor signaling increases neurogenesis and suppresses anxiety through NFATc4. | 1.41e-05 | 3 | 76 | 2 | 24948817 | |
| Pubmed | Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis. | 1.41e-05 | 3 | 76 | 2 | 21722213 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 15777793 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 12799135 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 29135068 | ||
| Pubmed | Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. | 1.41e-05 | 3 | 76 | 2 | 27322543 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 34615997 | ||
| Pubmed | 1.55e-05 | 242 | 76 | 6 | 34011540 | ||
| Pubmed | 1.83e-05 | 147 | 76 | 5 | 16959763 | ||
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 2.51e-05 | 26 | 76 | 3 | 17124501 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 10441327 | ||
| Pubmed | SAD-B Phosphorylation of CAST Controls Active Zone Vesicle Recycling for Synaptic Depression. | 2.82e-05 | 4 | 76 | 2 | 27626661 | |
| Pubmed | Genome-Wide Association Mapping for Female Infertility in Inbred Mice. | 2.82e-05 | 4 | 76 | 2 | 27449513 | |
| Pubmed | Nup358 interacts with APC and plays a role in cell polarization. | 2.82e-05 | 4 | 76 | 2 | 19654215 | |
| Pubmed | Identification of a link between the tumour suppressor APC and the kinesin superfamily. | 2.82e-05 | 4 | 76 | 2 | 11912492 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 12391317 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 29996090 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 18615096 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 31534167 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 26514622 | ||
| Pubmed | Fusion Competent Synaptic Vesicles Persist upon Active Zone Disruption and Loss of Vesicle Docking. | 2.82e-05 | 4 | 76 | 2 | 27537483 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 3.30e-05 | 565 | 76 | 8 | 25468996 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 3.78e-05 | 171 | 76 | 5 | 20201926 | |
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 20386726 | ||
| Pubmed | ELKS1 Captures Rab6-Marked Vesicular Cargo in Presynaptic Nerve Terminals. | 4.69e-05 | 5 | 76 | 2 | 32521280 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 20457185 | ||
| Pubmed | Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. | 7.03e-05 | 6 | 76 | 2 | 19525941 | |
| Pubmed | Chromosomal localization reveals three kinesin heavy chain genes in mouse. | 7.03e-05 | 6 | 76 | 2 | 9782088 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 32876667 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 31746486 | ||
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 7.04e-05 | 195 | 76 | 5 | 17110338 | |
| Pubmed | 8.20e-05 | 104 | 76 | 4 | 9205841 | ||
| Pubmed | Novel Cul3 binding proteins function to remodel E3 ligase complexes. | 9.35e-05 | 40 | 76 | 3 | 25011449 | |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 1454056 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 7560270 | ||
| Pubmed | Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites. | 9.83e-05 | 7 | 76 | 2 | 29398114 | |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 11487538 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 9.83e-05 | 7 | 76 | 2 | 35176221 | |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 16080114 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 24204315 | ||
| Pubmed | RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. | 9.83e-05 | 7 | 76 | 2 | 18772112 | |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 27053111 | ||
| Pubmed | 1.02e-04 | 110 | 76 | 4 | 27889896 | ||
| Pubmed | 1.09e-04 | 497 | 76 | 7 | 23414517 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 8175718 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 20613673 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.56e-04 | 231 | 76 | 5 | 16452087 | |
| Pubmed | 1.58e-04 | 708 | 76 | 8 | 39231216 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.59e-04 | 232 | 76 | 5 | 25515538 | |
| Pubmed | 1.62e-04 | 233 | 76 | 5 | 29518331 | ||
| Pubmed | 1.68e-04 | 9 | 76 | 2 | 12923177 | ||
| Pubmed | 1.68e-04 | 9 | 76 | 2 | 9733766 | ||
| Pubmed | 1.68e-04 | 9 | 76 | 2 | 8589683 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.84e-04 | 724 | 76 | 8 | 36232890 | |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 2.06e-04 | 132 | 76 | 4 | 16944949 | |
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 2.10e-04 | 10 | 76 | 2 | 21789198 | |
| Pubmed | 2.29e-04 | 251 | 76 | 5 | 27507650 | ||
| Pubmed | 2.56e-04 | 11 | 76 | 2 | 7832766 | ||
| Pubmed | 2.56e-04 | 11 | 76 | 2 | 7713516 | ||
| Pubmed | 2.56e-04 | 11 | 76 | 2 | 28262416 | ||
| Pubmed | 2.56e-04 | 11 | 76 | 2 | 35988140 | ||
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 2.56e-04 | 11 | 76 | 2 | 9924185 | |
| Pubmed | Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. | 2.56e-04 | 11 | 76 | 2 | 15866163 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 2.56e-04 | 11 | 76 | 2 | 38894703 | |
| Pubmed | 2.56e-04 | 11 | 76 | 2 | 17698926 | ||
| Pubmed | 2.71e-04 | 407 | 76 | 6 | 12693553 | ||
| Cytoband | 4p12 | 5.04e-04 | 20 | 76 | 2 | 4p12 | |
| Cytoband | 10q23.33 | 6.69e-04 | 23 | 76 | 2 | 10q23.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p12 | 8.57e-04 | 26 | 76 | 2 | chr4p12 | |
| Cytoband | 15q13.3 | 8.57e-04 | 26 | 76 | 2 | 15q13.3 | |
| Cytoband | 2p15 | 1.22e-03 | 31 | 76 | 2 | 2p15 | |
| Cytoband | 17p11.2 | 2.38e-03 | 159 | 76 | 3 | 17p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p15 | 2.45e-03 | 44 | 76 | 2 | chr2p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p11 | 4.72e-03 | 203 | 76 | 3 | chr17p11 | |
| Cytoband | 5q31.1 | 4.95e-03 | 63 | 76 | 2 | 5q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 5.41e-03 | 423 | 76 | 4 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p14 | 5.58e-03 | 67 | 76 | 2 | chr4p14 | |
| Cytoband | 12q13.13 | 5.58e-03 | 67 | 76 | 2 | 12q13.13 | |
| GeneFamily | Fibronectin type III domain containing | 1.15e-03 | 160 | 52 | 4 | 555 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.34e-03 | 19 | 52 | 2 | 563 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.65e-03 | 21 | 52 | 2 | 813 | |
| Coexpression | FAN_EMBRYONIC_CTX_ASTROCYTE_2 | 5.81e-06 | 154 | 76 | 6 | M39034 | |
| Coexpression | GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP | 2.50e-05 | 199 | 76 | 6 | M8324 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 2.57e-05 | 200 | 76 | 6 | M4456 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_UP | 3.33e-05 | 126 | 76 | 5 | M16381 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EHBP1 USP34 RANBP2 TRIM2 AUH ERC1 SEPTIN9 ARID5B APC RAPGEF2 PLCE1 | 3.49e-05 | 856 | 76 | 11 | M4500 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | LIFR NCOR1 PTPRB ADGRE3 ARID5B SORBS1 RAPGEF2 PGM2 MPRIP PLCE1 GABRA4 | 4.87e-05 | 888 | 76 | 11 | MM1018 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-10 | 184 | 76 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-10 | 184 | 76 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-10 | 184 | 76 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-08 | 186 | 76 | 7 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-07 | 168 | 76 | 6 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-07 | 181 | 76 | 6 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-07 | 183 | 76 | 6 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-07 | 188 | 76 | 6 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.96e-07 | 190 | 76 | 6 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.53e-07 | 192 | 76 | 6 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 194 | 76 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-06 | 199 | 76 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-06 | 200 | 76 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-06 | 200 | 76 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | BAL-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 6.69e-06 | 154 | 76 | 5 | 0121d08cc527aed9b3e11ff62bb9012916f5c56b | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-06 | 158 | 76 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-06 | 158 | 76 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.08e-05 | 170 | 76 | 5 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-05 | 173 | 76 | 5 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 175 | 76 | 5 | 26bd957498e41a3f1ffa60d3effa27ca8c4ba631 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 179 | 76 | 5 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-05 | 184 | 76 | 5 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 186 | 76 | 5 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-05 | 187 | 76 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 187 | 76 | 5 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.75e-05 | 188 | 76 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.75e-05 | 188 | 76 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | severe_COVID-19-Plasmablast|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.80e-05 | 189 | 76 | 5 | 953143b2c2e87a4d8ef033a5fbb155fe62e9c78e | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.80e-05 | 189 | 76 | 5 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-05 | 189 | 76 | 5 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 190 | 76 | 5 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 190 | 76 | 5 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 190 | 76 | 5 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 190 | 76 | 5 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 190 | 76 | 5 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.94e-05 | 192 | 76 | 5 | 7ab626a516b07d899175ff12f1c8257688324e4b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-05 | 193 | 76 | 5 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-05 | 193 | 76 | 5 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.99e-05 | 193 | 76 | 5 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-05 | 193 | 76 | 5 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-05 | 194 | 76 | 5 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | Caecum-T_cell-Tfh|T_cell / Region, Cell class and subclass | 2.14e-05 | 196 | 76 | 5 | fe2ee5788028e6b671674f0cc50e2b6379f50976 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 196 | 76 | 5 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.20e-05 | 197 | 76 | 5 | 9fcfbfbe78e8fe90c76eb37a58ed9dc8ece652a1 | |
| ToppCell | MS-CD4-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 2.20e-05 | 197 | 76 | 5 | eb0d4849de4ca374bd9c1e138d4f2b9c19227b15 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.25e-05 | 198 | 76 | 5 | f701d06e3d7fd2192afae3698c5ec3c355e96da3 | |
| ToppCell | IIH-CD4-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 2.25e-05 | 198 | 76 | 5 | 85414b283bbcdbf3393ab1b4302ef0e21c7a8181 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.30e-05 | 199 | 76 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Caecum-(1)_T_cell-(16)_Tfh|Caecum / shred on region, Cell_type, and subtype | 2.30e-05 | 199 | 76 | 5 | d07d77ae426dd1164d80d7031f14befa0369d3e5 | |
| ToppCell | Caecum-T_cell-Tfh|Caecum / Region, Cell class and subclass | 2.30e-05 | 199 | 76 | 5 | fb40f37d842f170ed101dfa3bffdb8f3b2c94f19 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-05 | 200 | 76 | 5 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.36e-05 | 200 | 76 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-05 | 200 | 76 | 5 | 68b0f987c4fb8078675475f4f1e71302f832ef69 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-05 | 200 | 76 | 5 | 1b527bebbca1ef8c52449e40beb9358e37494e04 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_Naive|URO / Disease, Lineage and Cell Type | 8.17e-05 | 134 | 76 | 4 | 142b7db0c2b686c8f2704ff7bcd9b44dfcb07403 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 142 | 76 | 4 | 6a656d28c9f5dfb03a3a2d908cf2edbe0a5b1206 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 142 | 76 | 4 | 671ba8869db7a6dc69fd1caf0e561f15a312b170 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 142 | 76 | 4 | 3557084150670fd2e2634fc674f228ab85181b59 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 142 | 76 | 4 | a3d1f4b570b75402171e38c5a7c88e2896520c8f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-04 | 144 | 76 | 4 | 748f4efc59f7afbce6c497524f36d852b8b1d637 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 146 | 76 | 4 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-04 | 146 | 76 | 4 | df865558d1843f3857ebd1529cebc540d3554c59 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 157 | 76 | 4 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 157 | 76 | 4 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-04 | 159 | 76 | 4 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | Healthy/Control-CD8+_T_naive|Healthy/Control / Disease group and Cell class | 1.62e-04 | 160 | 76 | 4 | e1386c21fcbbf57fa32d8bdfba3cb1887477ff73 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs|GI_large-bowel / Manually curated celltypes from each tissue | 1.70e-04 | 162 | 76 | 4 | 9a5e65c45f73a6a685b8362aa2e6aea77181caa3 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.95e-04 | 168 | 76 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 168 | 76 | 4 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 169 | 76 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 170 | 76 | 4 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 170 | 76 | 4 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-04 | 172 | 76 | 4 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.14e-04 | 172 | 76 | 4 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| ToppCell | Influenza_Severe-CD4+_Tcm|Influenza_Severe / Disease group and Cell class | 2.14e-04 | 172 | 76 | 4 | 47865a04968ca28c6ff125159d9a23e37c8b8af1 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.23e-04 | 174 | 76 | 4 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.23e-04 | 174 | 76 | 4 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 174 | 76 | 4 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 174 | 76 | 4 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 175 | 76 | 4 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 175 | 76 | 4 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 176 | 76 | 4 | ac3dc44755280e36c0947b6de3cd639dc17de8b6 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 177 | 76 | 4 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.43e-04 | 178 | 76 | 4 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 178 | 76 | 4 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| Drug | Securinine [5610-40-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 3.64e-06 | 192 | 76 | 7 | 3470_UP | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A | 4.03e-06 | 195 | 76 | 7 | 6799_DN | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; HL60; HT_HG-U133A | 4.03e-06 | 195 | 76 | 7 | 2446_DN | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A | 4.17e-06 | 196 | 76 | 7 | 4372_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 4.45e-06 | 198 | 76 | 7 | 4171_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; HL60; HT_HG-U133A | 4.45e-06 | 198 | 76 | 7 | 2542_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 4.60e-06 | 199 | 76 | 7 | 7156_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 4.72e-05 | 194 | 76 | 6 | 2430_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.86e-05 | 195 | 76 | 6 | 2308_DN | |
| Drug | carmustine; Up 200; 100uM; MCF7; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 6888_UP | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 7027_DN | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 6607_UP | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 4491_DN | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 4238_DN | |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 2631_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; HL60; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 2668_DN | |
| Drug | (1)-Nipecotic acid [498-95-3]; Up 200; 31uM; MCF7; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 6500_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; PC3; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 5723_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; HL60; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 2708_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 7391_UP | |
| Drug | Bromperidol [10457-90-6]; Up 200; 9.6uM; HL60; HG-U133A | 5.29e-05 | 198 | 76 | 6 | 1723_UP | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 5262_DN | |
| Drug | Ebselen [60940-34-3]; Down 200; 14.6uM; HL60; HT_HG-U133A | 5.44e-05 | 199 | 76 | 6 | 2717_DN | |
| Drug | Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; HL60; HT_HG-U133A | 5.44e-05 | 199 | 76 | 6 | 3138_DN | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 5.44e-05 | 199 | 76 | 6 | 5541_DN | |
| Drug | sodium | ACTL7A NAT1 PTPRB GART CLDN16 KCNN3 SLC4A4 SLC24A1 SLC7A11 HSPA9 GABRA2 GABRA4 | 6.47e-05 | 944 | 76 | 12 | CID000000923 |
| Drug | Lorazepam | 1.09e-04 | 5 | 76 | 2 | ctd:D008140 | |
| Drug | AC1LD8HW | 1.16e-04 | 75 | 76 | 4 | CID000644061 | |
| Drug | 3-isothujone | 1.36e-04 | 30 | 76 | 3 | CID000011027 | |
| Drug | Meprobamate | 1.64e-04 | 6 | 76 | 2 | DB00371 | |
| Drug | Flunitrazepam | 1.64e-04 | 6 | 76 | 2 | DB01544 | |
| Drug | MgCl2 | 1.80e-04 | 354 | 76 | 7 | CID000024584 | |
| Drug | 4-anisidine | 2.77e-04 | 38 | 76 | 3 | ctd:C013813 | |
| Drug | C15H20O3 | 3.01e-04 | 175 | 76 | 5 | CID000004692 | |
| Drug | Ro 15-4513 | 3.04e-04 | 8 | 76 | 2 | ctd:C042957 | |
| Drug | glutamate | ACTL7A AUH HPD ERC1 GART SLC4A4 SLC7A11 HTT GABRA2 PLCE1 GABRA4 | 3.35e-04 | 962 | 76 | 11 | CID000000611 |
| Drug | Ethchlorvynol | 3.90e-04 | 9 | 76 | 2 | DB00189 | |
| Drug | 8-azidoadenine | 3.90e-04 | 9 | 76 | 2 | CID003036161 | |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 3.98e-04 | 186 | 76 | 5 | 1228_UP | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; HL60; HT_HG-U133A | 3.98e-04 | 186 | 76 | 5 | 2353_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 3.98e-04 | 186 | 76 | 5 | 1177_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 4.08e-04 | 187 | 76 | 5 | 1043_UP | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.39e-04 | 190 | 76 | 5 | 5296_DN | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 4.39e-04 | 190 | 76 | 5 | 6825_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.50e-04 | 191 | 76 | 5 | 6020_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 4.50e-04 | 191 | 76 | 5 | 6498_UP | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 4.50e-04 | 191 | 76 | 5 | 7507_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 4.61e-04 | 192 | 76 | 5 | 6808_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.61e-04 | 192 | 76 | 5 | 2292_DN | |
| Drug | cyclosporine A; Up 200; 1uM; MCF7; HG-U133A | 4.61e-04 | 192 | 76 | 5 | 602_UP | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; HL60; HG-U133A | 4.72e-04 | 193 | 76 | 5 | 1715_UP | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; PC3; HT_HG-U133A | 4.72e-04 | 193 | 76 | 5 | 5101_DN | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A | 4.72e-04 | 193 | 76 | 5 | 4225_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; HL60; HT_HG-U133A | 4.72e-04 | 193 | 76 | 5 | 2567_DN | |
| Drug | Clotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 4.72e-04 | 193 | 76 | 5 | 6207_UP | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.72e-04 | 193 | 76 | 5 | 4205_DN | |
| Drug | NSC350854 | 4.72e-04 | 108 | 76 | 4 | CID000434448 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 1670_DN | |
| Drug | Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 7529_DN | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; MCF7; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 5342_DN | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; HL60; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 3021_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 3747_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 2621_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 3384_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 6507_UP | |
| Drug | Secobarbital | 4.86e-04 | 10 | 76 | 2 | DB00418 | |
| Drug | Chlordiazepoxide | 4.86e-04 | 10 | 76 | 2 | DB00475 | |
| Drug | Metharbital | 4.86e-04 | 10 | 76 | 2 | DB00463 | |
| Drug | Pentobarbital | 4.86e-04 | 10 | 76 | 2 | DB00312 | |
| Drug | Talbutal | 4.86e-04 | 10 | 76 | 2 | DB00306 | |
| Drug | Clobazam | 4.86e-04 | 10 | 76 | 2 | DB00349 | |
| Drug | Butalbital | 4.86e-04 | 10 | 76 | 2 | DB00241 | |
| Drug | Butabarbital | 4.86e-04 | 10 | 76 | 2 | DB00237 | |
| Drug | Bromazepam | 4.86e-04 | 10 | 76 | 2 | DB01558 | |
| Drug | Barbituric acid derivative | 4.86e-04 | 10 | 76 | 2 | DB01496 | |
| Drug | Barbital | 4.86e-04 | 10 | 76 | 2 | DB01483 | |
| Drug | Hexobarbital | 4.86e-04 | 10 | 76 | 2 | DB01355 | |
| Drug | Aprobarbital | 4.86e-04 | 10 | 76 | 2 | DB01352 | |
| Drug | Amobarbital | 4.86e-04 | 10 | 76 | 2 | DB01351 | |
| Drug | Heptabarbital | 4.86e-04 | 10 | 76 | 2 | DB01354 | |
| Drug | Butethal | 4.86e-04 | 10 | 76 | 2 | DB01353 | |
| Drug | AC1L1FKW | 4.86e-04 | 10 | 76 | 2 | CID000003281 | |
| Drug | Methylphenobarbital | 4.86e-04 | 10 | 76 | 2 | DB00849 | |
| Drug | Oxazepam | 4.86e-04 | 10 | 76 | 2 | DB00842 | |
| Drug | Primidone | 4.86e-04 | 10 | 76 | 2 | DB00794 | |
| Drug | Midazolam | 4.86e-04 | 10 | 76 | 2 | DB00683 | |
| Drug | Flurazepam | 4.86e-04 | 10 | 76 | 2 | DB00690 | |
| Drug | Clonazepam | 4.86e-04 | 10 | 76 | 2 | DB01068 | |
| Drug | thymol | 4.89e-04 | 46 | 76 | 3 | CID000006989 | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 2681_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 2701_DN | |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 3472_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 4309_UP | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 2475_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.94e-04 | 195 | 76 | 5 | 1045_UP | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 3272_UP | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; PC3; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 5834_UP | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; HL60; HT_HG-U133A | 5.06e-04 | 196 | 76 | 5 | 2440_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 5.06e-04 | 196 | 76 | 5 | 1155_UP | |
| Drug | PF-00875133-00 [351322-64-0]; Down 200; 10uM; PC3; HT_HG-U133A | 5.06e-04 | 196 | 76 | 5 | 5928_DN | |
| Disease | renal tubular transport disease (is_implicated_in) | 6.37e-06 | 2 | 75 | 2 | DOID:447 (is_implicated_in) | |
| Disease | phosphatidylcholine 40:6 measurement | 1.05e-05 | 17 | 75 | 3 | EFO_0010389 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology) | 1.91e-05 | 3 | 75 | 2 | DOID:0110274 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 1.91e-05 | 3 | 75 | 2 | DOID:0110282 (implicated_via_orthology) | |
| Disease | adenocarcinoma (is_implicated_in) | 3.81e-05 | 4 | 75 | 2 | DOID:299 (is_implicated_in) | |
| Disease | endoplasmic reticulum aminopeptidase 1 measurement | 1.33e-04 | 7 | 75 | 2 | EFO_0008119 | |
| Disease | Schizophrenia | 3.97e-04 | 883 | 75 | 9 | C0036341 | |
| Disease | Malignant neoplasm of liver | 4.79e-04 | 142 | 75 | 4 | C0345904 | |
| Disease | Liver neoplasms | 4.79e-04 | 142 | 75 | 4 | C0023903 | |
| Disease | anemia (implicated_via_orthology) | 6.55e-04 | 15 | 75 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | triacylglycerol 46:0 measurement | 6.55e-04 | 15 | 75 | 2 | EFO_0010400 | |
| Disease | respiratory symptom measurement, COVID-19 | 8.98e-04 | 74 | 75 | 3 | EFO_0007939, MONDO_0100096 | |
| Disease | Prostatic Neoplasms | 9.72e-04 | 616 | 75 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 9.72e-04 | 616 | 75 | 7 | C0376358 | |
| Disease | urate measurement, bone density | 1.00e-03 | 619 | 75 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | cardiovascular disease | 1.09e-03 | 457 | 75 | 6 | EFO_0000319 | |
| Disease | vital capacity | EHBP1 USP34 NCOR1 ERC1 SEPTIN9 SPSB1 ARID5B ERC2 ZFP82 PLCE1 | 1.12e-03 | 1236 | 75 | 10 | EFO_0004312 |
| Disease | alcohol consumption measurement | NDST3 EHBP1 PTPRB ARID5B GALNT7 WDR76 HTT STAT6 GABRA2 GABRA4 | 1.16e-03 | 1242 | 75 | 10 | EFO_0007878 |
| Disease | muscular dystrophy (implicated_via_orthology) | 1.30e-03 | 21 | 75 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | migraine disorder, Headache | 1.39e-03 | 86 | 75 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | Splenomegaly | 1.42e-03 | 22 | 75 | 2 | C0038002 | |
| Disease | Malignant neoplasm of breast | 1.58e-03 | 1074 | 75 | 9 | C0006142 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 1.96e-03 | 97 | 75 | 3 | EFO_0007878, EFO_0009458 | |
| Disease | Colorectal Carcinoma | 2.05e-03 | 702 | 75 | 7 | C0009402 | |
| Disease | mosquito bite reaction size measurement | 2.11e-03 | 212 | 75 | 4 | EFO_0008378 | |
| Disease | indole-3-propionate measurement | 2.15e-03 | 27 | 75 | 2 | EFO_0010501 | |
| Disease | azoospermia (implicated_via_orthology) | 2.15e-03 | 27 | 75 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | eye morphology measurement | 2.34e-03 | 218 | 75 | 4 | EFO_0007858 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKGTTGAPKMVEYSQ | 226 | Q6P461 | |
| TTMLGGYVYSTPAKK | 86 | P18440 | |
| GTESYTSTAMAPKGI | 466 | Q6ZRH7 | |
| DTPKASKGSYMEVRT | 516 | P0C7U0 | |
| YGRVKRGSKVSPIMT | 186 | P10767 | |
| GVSMAKSYSAPRTET | 211 | Q9Y5I7 | |
| GKSKGRKYPPMDSDS | 821 | O95803 | |
| SSETSKAPKSGFEGM | 1706 | P49792 | |
| MYGSARSVGKVEPSS | 1 | Q8IUD2 | |
| TVRYFGMKPKSGEKE | 1331 | Q68DA7 | |
| STDKLPYVTMGSGSL | 161 | Q99436 | |
| VPGRKYMATVTSISG | 526 | P23467 | |
| KSPDSATVSGYDIMK | 976 | Q6WCQ1 | |
| RGEMKSYSPTQVREK | 171 | O60721 | |
| TKKSYSSTLRGMPSA | 576 | Q9NXD2 | |
| PAPKRGYSSEMKTED | 61 | Q13825 | |
| TSKAKESAEPMSGYP | 2386 | Q5SZK8 | |
| GKETIKSSTGEYTVM | 226 | P47869 | |
| SSCKYSGGVMKPLSR | 176 | Q9UGI6 | |
| TMRTSGTEPKIKYYA | 556 | Q96G03 | |
| IMGRKEPDSYDGITT | 256 | Q8IV20 | |
| KRSQPATKTEDYGMG | 1791 | Q93074 | |
| TGYMPRKASVGSAST | 461 | P48169 | |
| ASTTYPKGTMTLGRA | 71 | O15083 | |
| GKTTAEDGKCYTAMP | 121 | Q7Z5B4 | |
| AYKKMASEREGSGSS | 651 | P38646 | |
| GKETGTPISMKDVYE | 401 | P09884 | |
| AYTMKGDGARSKPKV | 811 | Q13332 | |
| KEIRPTYAGSKSAME | 86 | O75956 | |
| MYTGKEKVSPGRTSD | 2926 | P42858 | |
| PMIKVSEGKYRVGDS | 226 | Q99501 | |
| KTKTEPYRSPAMAGG | 376 | Q86SF2 | |
| ARSGVKMSELPSYGE | 876 | Q8NDI1 | |
| SSKSMDRVYGKPRTT | 1016 | Q16760 | |
| TLQSEEDSRYMKPGK | 121 | Q6P179 | |
| EGTKSYVPYRDSKMT | 271 | Q12840 | |
| LFYRMPGGKEVTSTE | 476 | Q05BV3 | |
| SGEPTKTSLGMYSKE | 1646 | Q9NYC9 | |
| KDMRKLGYDTGPSDT | 176 | Q9UPM9 | |
| DGGVGPEKSMYVVTK | 816 | P42702 | |
| MTTYSDKGAKPERGR | 1 | P32754 | |
| ATYGTDKPDTRFGMK | 326 | Q6PI48 | |
| EKPVGGLSSSDTMDY | 2286 | Q9P212 | |
| YMSTDSAIPFGEKKR | 636 | Q9Y2K3 | |
| KPYDGITTIKEMGRS | 1336 | O75376 | |
| SMRQTSSGYGREKPS | 106 | Q7Z5V6 | |
| MKKSYSGGTRTSSGR | 1 | Q9UHD8 | |
| MDTTYSPIGGKVSDK | 371 | Q9UKZ4 | |
| LKSTMGSSFSYPDVK | 151 | Q8NAX2 | |
| STTVGKPYMETAKTG | 96 | Q9Y615 | |
| YTLSSKMGPDSKPSE | 626 | Q9BY15 | |
| TMSGPKKYPESLSRS | 961 | Q14865 | |
| SVSSSDGYGKRGQMK | 966 | P25054 | |
| SSSKMGYFPTEEKSE | 731 | Q9HAW4 | |
| TYRTFLSSPMEVGKK | 301 | Q9Y4G8 | |
| MVRKPVVSTISKGGY | 1 | Q9UPY5 | |
| FISVNTPTKTYGMGK | 86 | O60701 | |
| RKEKGIPSSQTYESM | 416 | Q8NB66 | |
| AGGIPSMSTKDLYAT | 516 | Q9NXZ1 | |
| TGGIKTVDMRDPTYR | 6 | Q96BD6 | |
| KPYSVGSDLSASKTM | 46 | Q8TDD2 | |
| GKTYTMEGIRGDPEK | 101 | O15066 | |
| KDGRGYVPATIKMTV | 636 | P42226 | |
| MREKEPIVGSTDYGK | 906 | Q13813 | |
| VPRSKSEMSYIDGEK | 476 | Q9BX66 | |
| TVVMASKGYPGDYTK | 336 | P22102 | |
| GLKAPECTSGMYKET | 106 | P36402 | |
| GYFSSVKMPSEKVSS | 136 | Q8N141 | |
| PGTSYEKLTSSSMGK | 436 | Q9H967 | |
| SLPSSDKRKNMYSGG | 396 | Q9Y6R1 | |
| DYGSSETPKMTRGVL | 251 | Q6UXY8 | |
| TPYTEDFLMGKSERK | 2116 | Q70CQ2 | |
| SMYSTGKRKENPIED | 456 | Q9C040 | |
| PSGSMDGVLDYSKTI | 486 | Q9P2L0 | |
| MYSTGGKRKDNPIED | 456 | O75382 | |
| SGVKPTGYRKRSSSM | 1631 | Q9ULV0 | |
| VKEEESRPGTYGMLS | 31 | Q9HD90 |